Gebbink; Martijn Frans Ben Gerard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gebbink; Martijn Frans Ben Gerard.The latest application filed is for "enhancement of immunogenicity of antigens".

Company Profile

0.2.15

Gebbink; Martijn Frans Ben Gerard - Eemnes NL
Gebbink; Martijn Frans Ben Gerard - Bunnik NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition Grant 8,114,832 - Gebbink , et al. February 14, 2	2012-02-14
Cross-.beta. structure binding compounds Grant 8,067,187 - Gebbink , et al. November 29, 2	2011-11-29
Enhancement Of Immunogenicity Of Antigens App 20110052564 - Gebbink; Martijn Frans Ben Gerard ; et al.	2011-03-03
Immunogenic Compositions Capable Of Activating T-cells App 20110008376 - Gebbink; Martijn Frans Ben Gerard ; et al.	2011-01-13
Methods of Binding of Cross-Beta Structures By Chaperones App 20100015126 - Gebbink; Martijn Frans Ben Gerard ; et al.	2010-01-21
Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With Blood Coagulation App 20090202980 - Gebbink; Martijn Frans Ben Gerard ; et al.	2009-08-13
Immunogenic compositions capable of activating T-cells App 20090191228 - Gebbink; Martijn Frans Ben Gerard ; et al.	2009-07-30
Affinity Regions App 20090155254 - Gebbink; Martijn Frans Ben Gerard ; et al.	2009-06-18
Immunogenic compositions App 20090142377 - Gebbink; Martijn Frans Ben Gerard ; et al.	2009-06-04
Croos-B Structure Binding Compounds App 20080267948 - Gebbink; Martijn Frans Ben Gerard ; et al.	2008-10-30
Methods for Determining the Effect of a Treatment on the Cross-Beta Structure Content of a Protein; Selection of Treatments and Uses Thereof App 20080249606 - Gebbink; Martijn Frans Ben Gerard ; et al.	2008-10-09
Method for Detecting and/or Removing Protein and/or Peptide Comprising a Cross-Beta Structure From an Aqueous Solution Comprising a Protein App 20080220446 - Gebbink; Martijn Frans Ben Gerard ; et al.	2008-09-11
Method for Detecting Peptides Comprising a Cross-B Structure App 20080207488 - Gebbink; Martijn Frans Ben Gerard ; et al.	2008-08-28
Adjuvation Through Cross -Beta Structure App 20080118529 - Gebbink; Martijn Frans Ben Gerard ; et al.	2008-05-22
Method for detecting and/or removing protien comprising a cross-beta structure from a pharmaceutical composition App 20070015206 - Gebbink; Martijn Frans Ben Gerard ; et al.	2007-01-18
Cross-beta structures on microbial organisms App 20060292683 - Gebbink; Martijn Frans Ben Gerard ; et al.	2006-12-28
Cross-beta structure comprising amyloid-binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity App 20060045853 - Kroon-Batenburg; Louise Maria Johanna ; et al.	2006-03-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.